Be informed: Understanding the FDA-required Prescribing Information     www.copaxone.com     YOU'RE INVITED TO VIEW A SPECIAL WEBCAST: UNDERSTANDING THE PRESCRIBING INFORMATION     Join us for a webcast led by Dr. Daniel Bandari, MD, MS, to learn more about a key source of information about any drug: the Prescribing Information (PI), including COPAXONE® (glatiramer acetate injection).   Click on your preferred time to watch one of the following webcasts on Wednesday, August 13, 2014:         12:00 PM EDT / 11:00 AM CDT / 9:00 AM PDT         1:00 PM EDT / 12:00 PM CDT / 10:00 AM PDT         3:00 PM EDT / 2:00 PM CDT / 12:00 PM PDT         6:30 PM EDT / 5:30 PM CDT / 3:30 PM PDT         7:30 PM EDT / 6:30 PM CDT / 4:30 PM PDT         9:30 PM EDT / 8:30 PM CDT / 6:30 PM PDT     You can also dial in to listen to a webcast at the times listed above.   Toll-free dial-in number: 1 (877) 365-9792 Conference code: 1230278012   For technical support, please call 1 (855) 341-2395. Live technical support assistance will be available starting 30 minutes prior to the webcast start time. Dr. Bandari has been recognized as one of the top neurologists in the nation specializing in multiple sclerosis. He is the Founder and Medical Director of the Multiple Sclerosis Center of California & Research Group.Dr. Bandari is also a Clinical Assistant Professor of Neurology and Neuro-immunology, and the Director of the Multiple Sclerosis Program of Hoag Neurosciences Institute in Orange County, California.       COPAXONE® (glatiramer acetate injection) is indicated for the treatment of patients with relapsing forms of multiple sclerosis.   Important Safety Information   Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol.   Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.   Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.   A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.   The most common side effects in studies of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®.   You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.   Please see full Prescribing Information.           Privacy Notice | One Click Unsubscribe | Terms of Use             COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered service mark of Teva Neuroscience, Inc. © 2014 Teva Neuroscience, Inc. COP-42008 Teva Neuroscience, Inc., COPAXONE® Marketing, 11100 Nall Avenue, Overland Park, KS 66211